According to media outlet SBS, Georgia has become the first state to allow the sale of medical marijuana in regular pharmacies. The Georgia Pharmacy Board began accepting applications for the sale of medical marijuana earlier this month.
As of now, over 120 out of more than 400 privately-owned pharmacies in Georgia have expressed their willingness to sell the medical cannabis oil from "Botanical Science" company. These pharmacies are expected to start selling medical cannabis shortly after the completion of a state government field inspection.
Although 38 states in the United States have legalized the use of medical marijuana, its purchase is currently limited to specialized marijuana dispensaries with government permits. If regular pharmacies were allowed to sell medical marijuana oil, the purchasing process for patients with prescriptions would become more convenient.
In 2019, the state of Georgia approved applications for the purchase of medical marijuana for patients suffering from epilepsy, late-stage cancer, and Parkinson's disease. Governor Brian Kemp of Georgia recently approved regulations for the sale of medical marijuana proposed by the Board of Pharmacy.
With a doctor's prescription and a registration certificate issued by the state government, patients and caregivers only need to present their identification cards to legally purchase medical cannabis oil under the guidance of a pharmacist.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
